OSR HEALTH, INC. Amortization of Intangible Assets
OSR HEALTH, INC. (OSRH) reported Amortization of Intangible Assets of $4.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-14
- OSR HEALTH, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $2.35M, a 0.08% increase year-over-year.
- OSR HEALTH, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $2.42M, a 6.38% increase year-over-year.
- OSR HEALTH, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $2.29M, a 100.33% increase year-over-year.
- OSR HEALTH, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $2.39M, a 15.25% decline year-over-year.
- OSR HEALTH, INC. amortization of intangible assets for fiscal 2025 was $9.30M, a 3.45% decline from fiscal 2024.
- OSR HEALTH, INC. amortization of intangible assets for fiscal 2024 was $9.63M.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $4.77M 10-Q · filed 2026-08-14 | $7.06M derived: sum of 3 quarters · filed 2026-08-14 | $9.45M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $2.42M 10-Q · filed 2026-05-13 | $4.71M derived: sum of 2 quarters · filed 2026-05-13 | $7.09M derived: sum of 3 quarters · filed 2026-05-13 | $9.44M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.67M derived: sum of 2 quarters · filed 2026-03-31 | $7.03M derived: sum of 3 quarters · filed 2026-08-14 | $9.30M 10-K · filed 2026-03-31 |
| 2025-09-30 | $2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $4.74M derived: sum of 2 quarters · filed 2026-08-14 | $7.01M 10-Q · filed 2025-11-12 | $8.15M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $4.62M 10-Q · filed 2026-08-14 | $5.77M derived: sum of 3 quarters · filed 2026-08-14 | $8.58M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.27M 10-Q · filed 2026-05-13 | $3.42M derived: sum of 2 quarters · filed 2026-05-13 | $6.23M derived: sum of 3 quarters · filed 2026-05-13 | $9.01M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $3.96M derived: sum of 2 quarters · filed 2026-03-31 | $6.73M derived: sum of 3 quarters · filed 2026-03-31 | $9.63M 10-K · filed 2026-03-31 |
| 2024-09-30 | $2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $5.59M derived: sum of 2 quarters · filed 2025-11-12 | $8.49M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $2.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $5.67M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $2.90M 10-Q · filed 2025-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |